Login / Signup

Assessment of Hormonal Contraceptive Utilization and Associated Odds of Hypercoagulopathy in Patients with Venous Malformations Using a National Claims Database.

Jami WangMollie F QianMichael R JengJoyce M C Teng
Published in: Clinical drug investigation (2023)
These findings suggest that patients with VM may safely use HCs with careful consideration of other risk factors for thromboses.
Keyphrases
  • health insurance
  • quality improvement
  • polycystic ovary syndrome
  • adverse drug
  • emergency department
  • metabolic syndrome
  • adipose tissue
  • skeletal muscle
  • electronic health record
  • drug induced